Diabetes Medication with Implantable Device Study

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes.

Register Today!

Trial Information

Trial Duration52 weeks
Number of Visits12
Lead CRCJason Collin

For additional information
on this trial contact: